Overview

Prevention of Gastric Ulcers

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDS) are often associated with gastric ulcers. This study looks at the prevention of these gastric ulcers with one of the three following treatment groups for up to 8 weeks: esomeprazole 40 mg once daily; esomeprazole 20 mg once daily; versus placebo; in patients at risk.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole